ProAssurance (NYSE:PRA - Get Free Report) is projected to announce its Q2 2025 earnings results before the market opens on Thursday, August 14th. Analysts expect ProAssurance to post earnings of $0.20 per share and revenue of $265.80 million for the quarter.
ProAssurance (NYSE:PRA - Get Free Report) last announced its quarterly earnings results on Tuesday, August 5th. The insurance provider reported $0.52 earnings per share for the quarter, topping analysts' consensus estimates of $0.19 by $0.33. ProAssurance had a return on equity of 5.68% and a net margin of 4.33%. The business had revenue of $271.94 million for the quarter, compared to analysts' expectations of $266.72 million. During the same period in the prior year, the firm earned $0.23 EPS. The business's quarterly revenue was down 19.9% on a year-over-year basis. On average, analysts expect ProAssurance to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.
ProAssurance Trading Up 0.2%
NYSE:PRA opened at $23.87 on Thursday. The firm has a market capitalization of $1.22 billion, a P/E ratio of 25.39 and a beta of 0.13. The business has a 50 day simple moving average of $23.38 and a 200 day simple moving average of $20.84. The company has a debt-to-equity ratio of 0.34, a current ratio of 0.26 and a quick ratio of 0.26. ProAssurance has a 12-month low of $11.27 and a 12-month high of $23.95.
Hedge Funds Weigh In On ProAssurance
A number of institutional investors and hedge funds have recently added to or reduced their stakes in PRA. AQR Capital Management LLC raised its position in ProAssurance by 40.4% in the first quarter. AQR Capital Management LLC now owns 134,641 shares of the insurance provider's stock worth $3,144,000 after acquiring an additional 38,756 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its position in shares of ProAssurance by 4.5% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 30,293 shares of the insurance provider's stock valued at $707,000 after purchasing an additional 1,302 shares in the last quarter. Millennium Management LLC grew its stake in shares of ProAssurance by 181.5% in the 1st quarter. Millennium Management LLC now owns 306,540 shares of the insurance provider's stock worth $7,158,000 after purchasing an additional 197,663 shares during the last quarter. Jones Financial Companies Lllp bought a new stake in shares of ProAssurance in the 1st quarter worth approximately $600,000. Finally, Goldman Sachs Group Inc. raised its holdings in shares of ProAssurance by 47.6% in the 1st quarter. Goldman Sachs Group Inc. now owns 511,759 shares of the insurance provider's stock worth $11,950,000 after purchasing an additional 165,024 shares in the last quarter. 85.58% of the stock is owned by institutional investors.
Analyst Upgrades and Downgrades
A number of research firms recently weighed in on PRA. Wall Street Zen started coverage on shares of ProAssurance in a report on Monday, May 19th. They issued a "hold" rating on the stock. Raymond James Financial lowered shares of ProAssurance from a "market perform" rating to an "underperform" rating in a research note on Thursday, April 10th. Finally, Piper Sandler boosted their price objective on ProAssurance from $18.00 to $25.00 and gave the stock a "neutral" rating in a research report on Thursday, May 8th. One research analyst has rated the stock with a sell rating and five have given a hold rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of "Hold" and an average target price of $21.50.
Check Out Our Latest Report on ProAssurance
ProAssurance Company Profile
(
Get Free Report)
ProAssurance Corporation, through its subsidiaries, provides property and casualty insurance, and reinsurance products in the United States. The company operates through Specialty Property and Casualty, Workers' Compensation Insurance, and Segregated Portfolio Cell Reinsurance segments. It offers professional liability insurance to healthcare providers and institutions, and attorneys and their firms; medical technology liability insurance to medical technology and life sciences companies; and custom alternative risk solutions, including assumed reinsurance, loss portfolio transfers, and captive cell programs for healthcare professional liability insureds.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider ProAssurance, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ProAssurance wasn't on the list.
While ProAssurance currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.